國家衛生研究院 NHRI:Item 3990099045/12066
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 956110      線上人數 : 802
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/12066


    題名: Metformin reduces risk of varicose veins in type 2 diabetes patients
    作者: Tseng, CH
    貢獻者: National Institute of Environmental Health Sciences
    摘要: AIM: This population-based retrospective cohort study compared the incidence of varicose veins in an unmatched cohort and a cohort of 1:1 propensity score (PS)-matched pairs of ever and never users of metformin in type 2 diabetes patients. METHODS: Patients with new-onset type 2 diabetes during 1999-2005 were enrolled from Taiwan's National Health Insurance and followed until December 31, 2011. Analyses were conducted in an unmatched cohort of 123,710 ever users and 15,095 never users and in 15,088 PS-matched pairs of ever users and never users. Hazard ratios were estimated by Cox proportional hazards model incorporated with the inverse probability of treatment weighting using the PS. RESULTS: New-onset varicose veins were diagnosed in 126 never users and 633 ever users in the unmatched cohort and in 126 never users and 80 ever users in the matched cohort. The respective incidences were 191.36 and 110.04 per 100,000 person-years in the unmatched cohort and 191.41 and 115.81 per 100,000 person-years in the matched cohort. The hazard ratio for ever versus never users in the unmatched cohort was 0.57 (95% confidence interval: 0.47-0.69); and was 0.60 (0.45-0.80) for the matched cohort. In the unmatched cohort, the hazard ratios for the first, second and third tertiles of cumulative duration were 1.03 (0.83-1.28), 0.55 (0.44-0.69) and 0.29 (0.23-0.37), respectively. The respective hazard ratios in the matched cohort were 0.97 (0.65-1.43), 0.79 (0.55-1.15) and 0.24 (0.13-0.42). CONCLUSION: Metformin use is associated with a lower risk of varicose veins in type 2 diabetes patients.
    日期: 2020-02
    關聯: Diabetes-Metabolism Research and Reviews. 2020 Feb;36(2):Article number e3206.
    Link to: http://dx.doi.org/10.1002/dmrr.3206
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1520-7552&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000487417000001
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85079018344
    顯示於類別:[其他] 期刊論文

    文件中的檔案:

    檔案 大小格式瀏覽次數
    PUB31322821.pdf1077KbAdobe PDF201檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋